[Comparison of the anorectic effect of mazindol and placebo in obesity]. 1979

J Tatoń, and A Czech, and P Koliński, and G Podwysocka

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008454 Mazindol Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter. AN-448,Diestet,Mazanor,Mazindole,Sanjorex,Sanorex,Solucaps,Teronac,Teronak,AN448
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001066 Appetite Natural recurring desire for food. Alterations may be induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS. Appetite Alterations,Alteration, Appetite,Alterations, Appetite,Appetite Alteration,Appetites

Related Publications

J Tatoń, and A Czech, and P Koliński, and G Podwysocka
August 1978, Irish journal of medical science,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
January 1989, Israel journal of medical sciences,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
December 1974, Drug and therapeutics bulletin,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
January 1978, La Clinica terapeutica,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
February 1975, Casopis lekaru ceskych,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
June 1977, La Clinica terapeutica,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
January 1995, Archives internationales de pharmacodynamie et de therapie,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
December 1994, Brain research,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
October 1976, The Medical journal of Australia,
J Tatoń, and A Czech, and P Koliński, and G Podwysocka
June 2021, Acta pharmaceutica (Zagreb, Croatia),
Copied contents to your clipboard!